Concepedia
Statistics
Publications
9
Citations
340
H-Index
Active since
2001
Affiliations
Kyowa Kirin (Japan)(Current)
Boehringer Ingelheim (Japan)
Kyoto University
National Cerebral and Cardiovascular Center
Yoichi Nishiya is an author at Kyowa Kirin (Japan) specializing in pharmacology, medicine, and life sciences.
Publications per year
2001–2025
The novel potent TEAD inhibitor, K-975, inhibits YAP1/TAZ-TEAD protein-protein interactions and exerts an anti-tumor effect on malignant pleural mesothelioma.
Ayumi Kaneda, Toshihiro Seike, Tomohiro Danjo et al. · PubMed · 2020 · 148 citations · Full text
Life Sciences, Molecular Biology, Oncology +16
Effects of Various Antihypertensive Drugs on the Function of Osteoblast.
Yoichi Nishiya, Seiji Sugimoto · Biological and Pharmaceutical Bulletin · 2001 · 48 citations · Full text
Medicine, Pharmacology, Pharmacotherapy +17
The SGLT2 inhibitor empagliflozin improves cardiac energy status via mitochondrial ATP production in diabetic mice
Jung-Mi Choi, Naoki Matoba, Daiki Setoyama et al. · Communications Biology · 2023 · 42 citations · Full text
Life Sciences, Cardiology, Pharmacology +17
A Potent 1,4-Dihydropyridine L-type Calcium Channel Blocker, Benidipine, Promotes Osteoblast Differentiation
Yoichi Nishiya, Nobuo Kosaka, Masako Uchii et al. · Calcified Tissue International · 2002 · 35 citations
Medicine, Pharmacology, Bone Metabolism +10
Solution structure of an RNA fragment with the P7/P9.0 region and the 3???-terminal guanosine of the Tetrahymena group I intron
Aya Kitamura, Y. Muto, Satoru Watanabe et al. · RNA · 2002 · 18 citations
Life Sciences, Biochemistry, Molecular Biology +15
1–5 of 9